EUVIMEDEUVIMED entdecken
Crossref

Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation

Yanfen Zheng iD, Ziqi Zhuang, Renwu Zhou, Luo Zheng, Changhong Li iD, Rusen Zhou, Yuting Gao, Liang Zhang iD, Yating Zheng, Liqian Zhao iD, Syed Faheem Askari Rizvi, Bocheng Yang und 12 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202403223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yanfen Zheng und 23 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Key Laboratory of Stomatological Disease Diagnosis and Treatment, Department of Pharmacy, Stomatological Hospital of Xiamen Medical College, X…. Hauptthemen laut MEDLINE: Plasma Gases, Nanogels, Oral Ulcer, Inflammation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral ulcers, affecting 27.9% of adults, can lead to malnutrition and dehydration, especially in individuals with diabetes, cancer, viral infections, and autoimmune diseases. Existing treatments—including oral films, sprays, frosts, and powders—often fail to be effective due to rapid dilution and clearance in the moist oral environment. This study is the first to investigate the use of Cold Atmospheric Plasma (CAP) for treating oral ulcers and its underlying molecular mechanisms. A novel high‐bioavailability, mucoadhesive therapy combining handheld three dimensions (3D) multi‐microhole CAP is developed with a nanogel‐based pharmaceutical system containing glucose oxidase (GOx) and catalase (CAT), termed GCN. These results showed that both CAP alone and CAP combined with GCN significantly accelerate oral ulcer healing, modulate immune responses, and activate the Epidermal Growth Factor Receptor (EGFR) in acetic acid‐induced oral ulcers, outperforming untreated controls and the conventional medication, Watermelon Frost (WF). Furthermore, the CAP+GCN combination enhances therapeutic effects by promoting fibroblast generation. CAP pretreatment also enhances cell permeability and nanoparticle uptake, improving tissue adhesion. These findings are validated in primary Human Gingival Fibroblasts (HGF) and Human Periodontal Ligament Stem Cells (PDLSC) from healthy donors, as well as an oral ulcer model in rats, demonstrating superior biocompatibility and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma GasesNanogelsOral UlcerInflammationAnimalsRatsMaleGlucose OxidaseRats, Sprague-DawleyHumansCatalaseWound Healing

Stichwörter der Autor:innen

Cold Atmospheric Plasma (CAP)Oral ulcersimmune regulationmucoadhesivenano‐gel

Substanzen

Plasma GasesNanogelsGlucose OxidaseCatalase

Autor:innen und Institutionen

  • Xiamen Key Laboratory of Stomatological Disease Diagnosis and Treatment, Department of Pharmacy, Stomatological Hospital of Xiamen Medical College, Xiamen, 361008, China.
  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, State Key Laboratory of Molecular Vaccinolo…
  • State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, 710049, China.
  • State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.
  • State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen, 361102, China.
  • Department of Dermatology, The Fourth Affiliated Hospital of Harbin Medical University, No.37, Yiyuan Street, Nangang District, Harbin, 150001, China.

ORCID-Profile: Yanfen Zheng, Changhong Li, Liang Zhang, Liqian Zhao, Jinyong Lin, Erik W Thompson, Gang Liu, Peiyu Wang

Förderung

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Fujian provincial health technology project
  • Fujian Basic and Applied Basic Research Foundation
  • Shanxi Provincial Natural Science Program
  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory

Zitieren

APA

Zheng, Y., Zhuang, Z., Zhou, R., Zheng, L., Li, C., Zhou, R., Gao, Y., Zhang, L., Zheng, Y., Zhao, L., Rizvi, S. F. A., Yang, B., Jiang, L., Lin, J., Wang, A., Zhou, W., Cheng, H., Li, D., Chu, C., …, & Wang, P. (2025). Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403223

Vancouver

Zheng Y, Zhuang Z, Zhou R, Zheng L, Li C, Zhou R, et al. Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403223

BibTeX
@article{Zheng2025,
  author = {Zheng, Yanfen and Zhuang, Ziqi and Zhou, Renwu and Zheng, Luo and Li, Changhong and Zhou, Rusen and Gao, Yuting and Zhang, Liang and Zheng, Yating and Zhao, Liqian and Rizvi, Syed Faheem Askari and Yang, Bocheng and Jiang, Lili and Lin, Jinyong and Wang, Anqi and Zhou, Wei and Cheng, Hongwei and Li, Dong and Chu, Chengchao and Thompson, Erik W and Wu, Yunlong and Liu, Gang and Zeng, Yun and Wang, Peiyu},
  title = {Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202403223}
}
Kostenlos starten →